Current concept on the pathogenesis of inflammatory bowel disease-crosstalk between genetic and microbial factors: Pathogenic bacteria and altered bacterial sensing or changes in mucosal integrity take "toll"?

被引:110
作者
Lakatos, Peter Laszlo
Fischer, Simon
Lakatos, Laszlo
Gal, Istvan
Papp, Janos
机构
[1] Semmelweis Univ, Dept Med 1, H-1083 Budapest, Hungary
[2] Csolnoky F Cty Hosp, Dept Med 1, Veszprem, Hungary
[3] Kenezi Gy Cty Hosp, Dept Med 2, Debrecen, Hungary
关键词
inflammatory bowel disease; ulcerative colitis; Crohn's disease; pathogenesis; microbial factors; genetics; NOD2/CARD15; SLC22A4/A5; DLG5;
D O I
10.3748/wjg.v12.i12.1829
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The pathogenesis of inflammatory bowel disease (IBD) is only partially understood. Various environmental and host (e.g. genetic-, epithelial-, immune and non-immune) factors are involved. It is a multifactorial polygenic disease with probable genetic heterogeneity. Some genes are associated with IBD itself, while others increase the risk of ulcerative colitis (UC) or Crohn's disease (CD) or are associated with disease location and/or behaviour. This review addresses recent advances in the genetics of IBD. The article discusses the current information on the crosstalk between microbial and genetic factors (e.g. NOD2/CARD15, SLC22A46A5 and DLG5). The genetic data acquired in recent years help in understanding the pathogenesis of IBD and can identify a number of potential targets for therapeutic intervention. In the future, genetics may help more accurately diagnose and predict disease course in IBD. (C) 2006 The WJG Press. All rights reserved.
引用
收藏
页码:1829 / 1841
页数:13
相关论文
共 172 条
[1]
Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease [J].
Abreu, MT ;
Taylor, KD ;
Lin, YC ;
Hang, T ;
Gaiennie, J ;
Landers, CJ ;
Vasiliauskas, EA ;
Kam, LY ;
Rojany, M ;
Papadakis, KA ;
Rotter, JI ;
Targan, SR ;
Yang, HY .
GASTROENTEROLOGY, 2002, 123 (03) :679-688
[2]
Clinical relevance of advances in genetics and pharmacogenetics of IBD [J].
Ahmad, T ;
Tamboli, CP ;
Jewell, D ;
Colombel, JF .
GASTROENTEROLOGY, 2004, 126 (06) :1533-1549
[3]
The contribution of human leucocyte antigen complex genes to disease phenotype in ulcerative colitis [J].
Ahmad, T ;
Armuzzi, A ;
Neville, M ;
Bunce, M ;
Ling, KL ;
Welsh, KI ;
Marshall, SE ;
Jewell, DP .
TISSUE ANTIGENS, 2003, 62 (06) :527-535
[4]
The molecular classification of the clinical manifestations of Crohn's disease [J].
Ahmad, T ;
Armuzzi, A ;
Bunce, M ;
Mulcahy-Hawes, K ;
Marshall, SE ;
Orchard, TR ;
Crawshaw, J ;
Large, O ;
De Silva, A ;
Cook, JT ;
Barnardo, M ;
Cullen, S ;
Welsh, KI ;
Jewell, DP .
GASTROENTEROLOGY, 2002, 122 (04) :854-866
[5]
Role of polymorphisms in the interleukin-10 gene in determining disease susceptibility and phenotype in inflamatory bowel disease [J].
Aithal, GP ;
Craggs, A ;
Day, CP ;
Welfare, M ;
Daly, AK ;
Mansfield, JC ;
Hudson, M .
DIGESTIVE DISEASES AND SCIENCES, 2001, 46 (07) :1520-1525
[6]
NOD2/CARD15 and the Paneth cell: another piece in the genetic jigsaw of inflammatory bowel disease [J].
Aldhous, MC ;
Nimmo, ER ;
Satsangi, J .
GUT, 2003, 52 (11) :1533-1535
[7]
NOD2 3020insC alone is not sufficient for colorectal cancer predisposition [J].
Alhopuro, P ;
Ahvenainen, T ;
Mecklin, JP ;
Juhola, M ;
Järvinen, HJ ;
Karhu, A ;
Aaltonen, LA .
CANCER RESEARCH, 2004, 64 (20) :7245-7247
[8]
Crohn's disease: Concordance for site and clinical type in affected family members - Potential hereditary influences [J].
Bayless, TM ;
Tokayer, AZ ;
Polito, JM ;
Quaskey, SA ;
Mellits, ED ;
Harris, ML .
GASTROENTEROLOGY, 1996, 111 (03) :573-579
[9]
Population-based case control study of seroprevalence of Mycobacterium paratuberculosis in patients with Crohn's disease and ulcerative colitis [J].
Bernstein, CN ;
Blanchard, JF ;
Rawsthorne, P ;
Collins, MT .
JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (03) :1129-1135
[10]
The genetics of inflammatory bowel disease [J].
Bonen, DK ;
Cho, JH .
GASTROENTEROLOGY, 2003, 124 (02) :521-536